ALLIANCEBERNSTEIN L.P. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 175 filers reported holding ANI PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,274,237
+15.9%
20,010
+25.8%
0.00%
Q1 2024$1,099,858
+39.7%
15,910
+11.4%
0.00%
Q4 2023$787,399
-5.0%
14,2800.0%0.00%
Q3 2023$829,097
+7.9%
14,2800.0%0.00%
Q2 2023$768,692
+49.4%
14,280
+10.3%
0.00%
Q1 2023$514,374
-13.3%
12,950
-12.2%
0.00%
Q4 2022$593,513
+25.5%
14,753
+0.2%
0.00%
Q3 2022$473,000
+7.3%
14,720
-0.9%
0.00%
Q2 2022$441,000
+6.0%
14,855
+0.5%
0.00%
Q1 2022$416,000
-37.7%
14,783
+2.0%
0.00%
Q4 2021$668,000
+15.6%
14,493
-17.7%
0.00%
Q3 2021$578,000
-8.7%
17,610
-2.5%
0.00%
Q2 2021$633,000
-19.2%
18,060
-16.7%
0.00%
Q1 2021$783,000
+38.8%
21,669
+11.6%
0.00%
Q4 2020$564,000
+9.7%
19,419
+6.6%
0.00%
Q3 2020$514,000
-16.0%
18,212
-3.8%
0.00%
Q2 2020$612,000
+6.6%
18,926
+34.2%
0.00%
Q1 2020$574,000
-35.8%
14,100
-2.8%
0.00%
-100.0%
Q4 2019$894,000
-15.1%
14,500
+0.3%
0.00%0.0%
Q3 2019$1,053,000
-20.7%
14,450
-10.5%
0.00%0.0%
Q2 2019$1,328,000
+83.7%
16,150
+57.6%
0.00%
Q1 2019$723,000
+56.8%
10,2500.0%0.00%
Q4 2018$461,000
-20.5%
10,2500.0%0.00%
Q3 2018$580,000
-15.3%
10,2500.0%0.00%
Q2 2018$685,000
+25.9%
10,250
+9.6%
0.00%
Q1 2018$544,000
-58.4%
9,350
-53.9%
0.00%
-100.0%
Q4 2017$1,308,000
+163.7%
20,288
+114.7%
0.00%
Q3 2017$496,000
+0.4%
9,450
-10.4%
0.00%
Q2 2017$494,000
+25.4%
10,550
+32.7%
0.00%
Q1 2017$394,000
-88.4%
7,950
-85.9%
0.00%
-100.0%
Q4 2016$3,410,000
-0.1%
56,250
+9.3%
0.00%0.0%
Q3 2016$3,414,000
+121.0%
51,450
+85.9%
0.00%
+200.0%
Q2 2016$1,545,000
+304.5%
27,680
+143.9%
0.00%
Q1 2016$382,000
-25.4%
11,3500.0%0.00%
Q4 2015$512,000
+14.3%
11,3500.0%0.00%
Q3 2015$448,000
-36.4%
11,3500.0%0.00%
-100.0%
Q2 2015$704,000
+185.0%
11,350
+187.3%
0.00%
Q1 2015$247,000
-18.2%
3,950
-26.2%
0.00%
Q4 2014$302,000
+282.3%
5,350
+91.1%
0.00%
Q3 2014$79,000
-17.7%
2,8000.0%0.00%
Q2 2014$96,000
+1500.0%
2,800
+1307.0%
0.00%
Q1 2014$6,000
+50.0%
1990.0%0.00%
Q4 2013$4,000
+100.0%
1990.0%0.00%
Q3 2013$2,0001990.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 426,162$17,362,0002.40%
Mesirow Financial Investment Management, Inc. 6,542$267,0001.68%
Global Alpha Capital Management Ltd. 217,746$8,871,0001.60%
Hawk Ridge Capital Management 196,661$8,012,0001.35%
1492 Capital Management LLC 25,070$1,021,0001.22%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,437$11,588,0000.75%
Regent Investment Management LLC 40,579$1,653,0000.68%
THB ASSET MANAGEMENT 52,964$2,157,0000.68%
GLOBEFLEX CAPITAL L P 38,155$1,554,0000.48%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$1,446,0000.39%
View complete list of ANI PHARMACEUTICALS INC shareholders